Contract Research Organization for the Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) Informed the Company that 78 Events have Occurred in the Trial as of May 11, ...
Digital Brands Group, Inc. ("DBG" or the "Company") (NASDAQ: DBGI), a publicly traded company specializing in apparel and e-commerce, today announced that it forecasts 2026 revenue of $55 to $65 ...
Xylem is globally recognized for sustainability, earning a place on the CDP Climate Change A List, recognition as one of TIME's 10 Most Influential Sustainability Companies in 2026, and the 41st spot ...